IN10
Diaceutics, diagnostics,
and precision medicine commercialization in ten minutes (or less).
Diaceutics
Diaceutics is the intelligence and engagement company unlocking the full potential for diagnostic-driven therapies.
Working at the intersection of data, science, and commercial strategy, Diaceutics’ goal is to ensure every eligible patient is identified, diagnosed, and receives the right therapy at precisely the right time.
We help biopharma teams find eligible patients earlier, understand where diagnostic pathways break down, and act while treatment decisions are still forming.
Powered by proprietary, near-real-time diagnostic data, AI-enabled technology and deep commercialization expertise, Diaceutics turns complex pathway signals into coordinated action across pre-launch, launch and in-market growth. Supporting more than 700 therapies, Diaceutics helps close the gap between scientific innovation and what patients experience in the real world.
A Changing World
Personalized and diagnostically enabled therapies now represent a growing proportion of drug development pipelines, while healthcare systems are demanding better evidence of value, access and outcomes.
Healthcare systems contain persistent practice gaps across diagnosis and treatment. Testing is often missed, delayed, incomplete, or not acted on. Diagnostic pathways fragment across labs, clinicians, and care settings and eligible patients fall out of the pathway between diagnosis and treatment. This means that patients wait to be discovered and therapies underperform.
Traditional approaches to commercializing therapies are not designed to operate within the new reality. They are built for linear pathways and awareness-led demand.
Diagnostic Therapies
Diagnostic-driven therapies need a commercial strategy built around testing, eligibility and treatment timing—but the picture is often fragmented or arrives too late.
As a result, demand for integrated diagnostic data and real-world intelligence continues to increase.
How We're Unique
Working with 21 of the top 30 pharma companies, and supporting more than 700 therapies, our strength lies in our unique global lab network, unparalleled diagnostic and real-world data, AI-enabled technology, and world-class commercialization expertise.
Network
A deeply embedded diagnostic community connecting biopharma to 600+ US labs and the people shaping testing practice.
Experience
More than two decades of specialist expertise across diagnostic science, lab practice and therapy commercialization.
- Intelligence
Reveal
The diagnostic intelligence engine that shows where opportunity is emerging—and where to act next.
- Coordination
Relay
Coordinated partnership for precision medicine commercialization.
- Platform
DXRX
Proprietary, AI-enabled platform that makes the diagnostic pathway visible, usable and ready for action.
Our Tools
Diagnostic-driven therapies are too complex for siloed data and retrospective decisions. Powered by Diaceutics Reveal, our products draw on near-real-time visibility from our Lab Network to see testing as it happens.
We combine near-real-time diagnostic activity, Intelligence Solutions and Engagement Solutions, moving teams from diagnostic insight to coordinated action.
Our Impact
Diaceutics offers a more connected path to market for diagnostic-driven therapies.
This allows clients to move earlier, focus smarter and keep adoption growing.
Meaning less fragmentation, sharper prioritization and a clearer path from diagnosis to therapy.